Key terms
About ZIMV
Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. It operates through the Spine Products and Dental Products segments. The Spine Products segment offers spinal surgery solutions such as implants, instrumentation, biologics, and bone healing technologies to treat patients with back or neck pain caused by degenerative conditions, deformities, tumors or traumatic injury of the spine. The Dental Products segment provides dental implant solutions, biomaterial solutions, and digital dentistry. The company was founded on November 4, 2021 and is headquartered in Westminster, CO.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ZIMV news
Apr 01
8:13am ET
ZimVie Inc Finalizes Strategic Spine Business Sale for $375M
Apr 01
8:12am ET
ZimVie estimates cash of $66M as of April 2
Apr 01
8:10am ET
ZimVie closes sale of Spine business
Mar 05
5:23am ET
ZimVie price target raised to $16 from $13 at Barclays
Mar 05
3:11am ET
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), ZimVie Inc (ZIMV) and Veeva Systems (VEEV)
Feb 29
6:15am ET
Needham Sticks to Its Hold Rating for ZimVie Inc (ZIMV)
Feb 28
4:22pm ET
ZimVie Inc Enhances Transparency with Supplementary Financial Data
Feb 08
5:26am ET
ZimVie Inc (ZIMV) Gets a Hold from Needham
Feb 07
4:15pm ET
ZimVie launches TSX Implant in Japan
Jan 04
6:19am ET
ZimVie price target raised to $13 from $11 at Barclays
No recent press releases are available for ZIMV
ZIMV Financials
Key terms
Ad Feedback
ZIMV Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ZIMV Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
